Browsing Tag

Chardan

Chardan NexTech Acquisition 2 Corp. Shareholders Approve Previously Announced…

Dustin Moskovitz Oct 7, 2022 0

RENO, Nev., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Chardan NexTech Acquisition 2 Corp. (“CNTQ”) (Nasdaq: CNTQ), a publicly traded special purpose acquisition company, today announced that its…

Health

Iovance Biotherapeutics to Present at Chardan Genetic Medicines and Cell Therapy…

Eli Pacheco Apr 26, 2022 0

SAN CARLOS, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer…

Health

Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell…

Eli Pacheco Apr 19, 2022 0

Chief Executive Officer, Chief Technical Officer, Chief Medical Officer and Head of Research and Development and Senior Vice President of Manufacturing to participate in a panel discussion…

Health

Synlogic To Present at Upcoming Investor and Industry Conferences

Eli Pacheco Feb 24, 2022 0

CAMBRIDGE, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases…

Health

Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic…

Eli Pacheco Sep 28, 2021 0

BERKELEY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today…

Health

Wave Life Sciences to Present at the Chardan Virtual Genetic Medicines Conference

Eli Pacheco Sep 23, 2021 0

CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for…